Ssd Af

   
Google
 
Web NewDrugInformation.com

Ssd Af


Drug - Ssd Af
The trade name of the product as shown on the labeling.

Dosage - CREAM; TOPICAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Silver Sulfadiazine
Multiple ingredients are in alphabetical order.

Strength - 1%
The potency of the active ingredient(s), Silver Sulfadiazine. May repeat for multiple part products.

Applicant - BASF
The firm name holding legal responsibility for Ssd Af. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 018578
The FDA assigned number to Ssd Af. Format is nnnnnn.

Product Number - 003
The FDA assigned number to identify Ssd Af. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - BX
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jul 11, 1990
The date Ssd Af was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Ssd Af. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Ssd Af is in. Format is RX, OTC, DISCN.

Applicant Full Name - Basf Corp
The full name of the firm holding legal responsibility for the new application of Ssd Af.

Ssd Af